Utilities, Consumer...
Response Genetics Inc. (RGDX: NASDAQ)
$1.65 -0.04 | -2.37%
02/09/12 - 03:59 PM ET
15.49K / 14.60K
Vol / Avg. Vol:1.68 / 1.69
Open / Prev. Close:1.65 - 1.75
Today's Range:0.81 - 3.05
52 Wk Range:7.84%
Performance YTD:TheStreet Rating:
Portfolios with RGDX
- Portfolio NameUser Type
- Userjaysan Portfolio 1
- Usercurry Portfolio 1
- Usercharlesl950 Portfolio 1
- UserWACKJDDUDE Portfolio 1
Latest RGDX Headlines from TheStreet
- Maguire Properties, Compugen: Midday Volume Plays 05.11.10 | 11:05 am
- Director Sells $7.4M Worth of Copart 07.01.09 | 10:07 am
Press Releases for RGDX
- Response Genetics To Present At The 22nd Annual UBS Global Healthcare Services Conference - Business Wire 02.06.12 | 07:02 am
- Response Genetics Raises More Than $7.8 Million In Financing - Business Wire 02.02.12 | 07:02 am
- Response Genetics Names Thomas A. Bologna Chairman And CEO - Business Wire 12.22.11 | 08:12 am
- Response Genetics, Inc. To Offer FDA-Approved ALK Test For Metastatic NSCLC - Business Wire 12.21.11 | 11:12 am
- Response Genetics, Inc. Reports Third Quarter Financial Results And Operational Update - Business Wire 11.10.11 | 08:11 am
- Response Genetics, Inc. To Release Third Quarter 2011 Financial Results - Business Wire 11.07.11 | 08:11 am
- Response Genetics To Present At 2011 UBS Global Life Sciences Conference - Business Wire 09.16.11 | 08:09 am
- Response Genetics, Inc. Reports Second Quarter Financial Results And Operational Update - Business Wire 08.08.11 | 08:08 am
- Response Genetics, Inc. To Release Second Quarter 2011 Financial Results - Business Wire 08.04.11 | 08:08 am
- Response Genetics Announces Search For New CEO - Business Wire 07.25.11 | 08:07 am
Partner Headlines for RGDX
- Response Genetics Stock Soars 31% On $7.8M Offering News - Seeking Alpha 02.03.12 | 08:02 am
- Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles - Seeking Alpha 07.07.10 | 07:07 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- Response Genetics: An Earnings Primer - Seeking Alpha 05.12.10 | 06:05 am
- UPDATE 1-Response Genetics inks deal with Glaxo, shares soar - Reuters 05.11.10 | 10:05 am





